1. Home
  2. ASIC vs MNKD Comparison

ASIC vs MNKD Comparison

Compare ASIC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

N/A

Current Price

$26.39

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$3.94

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASIC
MNKD
Founded
2018
1991
Country
United States
United States
Employees
203
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
ASIC
MNKD
Price
$26.39
$3.94
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
★ $29.10
$7.97
AVG Volume (30 Days)
51.7K
★ 3.7M
Earning Date
10-21-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.18
N/A
Revenue
★ $424,339,000.00
$348,966,000.00
Revenue This Year
$27.91
$27.07
Revenue Next Year
$25.28
$13.65
P/E Ratio
$22.21
★ N/A
Revenue Growth
★ 23.41
22.23
52 Week Low
$16.35
$2.23
52 Week High
$29.00
$6.51

Technical Indicators

Market Signals
Indicator
ASIC
MNKD
Relative Strength Index (RSI) 44.42 63.67
Support Level $18.75 $3.77
Resistance Level $27.22 $4.29
Average True Range (ATR) 0.80 0.21
MACD -0.30 0.05
Stochastic Oscillator 11.16 90.05

Price Performance

Historical Comparison
ASIC
MNKD

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: